What's new for citizens

From celiac disease to cancer screening, from telemedicine to 12-month prescriptions for chronic patients: how public health will change in 2026

The package on care, assistance, pharmaceutics and simplifications ready to go with the New Year: the focus on prevention, telemedicine and Alzheimer's is growing, but the knot of extra resources requested by the staff remains unresolved and they will have to make do with a series of 'tweaks'

by Barbara Gobbi

Adobe

10' min read

Translated by AI
Versione italiana

10' min read

Translated by AI
Versione italiana

It is a package full of many small novelties and adjustments that has been prepared for the health sector at the end of 2025 by the Government and Parliament and conveyed for 2026 by three measures: the budget law (Law 199/2025), the 'Milleproroghe' decree (Decree-Law 202/2025) currently being examined by Parliament for conversion into law, and the Simplification Law (Law 182/2025). The expected turnaround on adequate economic recognition of the National Health Service staff remains far off, from which in fact a chorus of discontent has arrived with the announcement of massive protests, but in the meantime the National Health Fund is growing, with a lot of resources earmarked for prevention and mental health - just to mention two hot topics - while from the point of view of the governance strategy of public resources for health, the level of funding of the Regions is finally linked to a verification of the improvements achieved by each on the Essential Levels of Care. There are also many other items, from attention to celiac disease to Ngs profiling for tumours to neonatal screening to the expansion of the age range for free mammography, from the quota reserved for the Alzheimer's scourge to the putting on track of the network of hospitals of excellence from the North to the South of the country and the full inclusion of pharmacies in the National Health Service. On the drugs front, the overall spending ceiling increases, but the fund for innovative products is reduced, while medical device companies collect a bittersweet result, with the spending ceiling still rising, but with a crackdown on the ministry's controls on the 0.75 per cent 'tax' on sales to the SSN.

And again, more money for purchases from accredited private individuals, telemedicine to be enhanced, the health card system crossing national borders, simplifications with family doctors' prescriptions for chronic patients valid for a year (under certain conditions). Until the bitter surprise for doctors and nurses, but above all for patients who risk losing the safety of care, inserted in extremis in the budget law: the extension of the derogation for foreign staff - introduced during the Covid emergency - until well into 2029. Yet it was the Minister of Health himself who had urged in Il Sole-24Ore the unblocking of the new discipline for the verification of the qualifications of all non-EU health workers, which has been at a standstill since April 2024 under examination by the State-Regions Conference.

Loading...

Below is a round-up of the main new developments.

Budget Law 2026

Health financing

The financing level of the standard National Health Requirement (NHF) to which the State contributes is 2,382.2 mln for 2026, 2,631 mln for 2027 and 2,633.1 mln from 2038. Among other items, this increase is for expenditure on Alzheimer's disease and other forms of senile dementia (100 mln for 2026, 98 mln for 2027 and 83.1 mln from 2028)

Budget Law, Art. 1 para. 333

Enhanced prevention

As of 2026, the resources allocated to the 'collective prevention and public health' level of care will increase permanently (238 million per year) from the increase in the National Social Security Fund: among other things, they will be used to extend mammography screening for breast cancer to women aged 45-49 and 70-74, to continue the lung cancer prevention and monitoring programme, to genomic and NGS tests for the diagnosis of deafness and the profiling of rare diseases, and to support vaccinations. For 2026 alone, an additional amount of 247 mln is allocated to prevention.

Budget Law, Art. 1 c. 340

Mental health

A share of the NSF (80 mln for 2026, 85 mln for 2027, 90 mln for 2028 and 30 mln per year from 2029) is earmarked to implement the measures envisaged in the National Plan of Actions for Mental Health (Pansm 2025-2030). From 2026, 30 mln is earmarked for the permanent recruitment of personnel to be employed in the mental health services, while 30% of the 2026-2028 quota is to be dedicated to prevention actions. A Health-Mef decree will allocate the overall resources among the Regions.

Budget Law, Art. 1, paras. 344-347

NHS rates

The annual funding for updating acute hospital tariffs increases by 350 mln per year to 1 billion in 2026 and 1.350 billion from 2027. The remuneration of the Lea (Essential Levels of Care) tariffs increases: 100 mln in 2026 and 183 mln from 2027, from the Fsn.

Budget Law, Art. 1, paras. 349-350

Pharmacies in the NHS

After the trial launched in 2018, pharmacies are permanently integrated into the National Health Service, as facilities 'providing health and social-health services'. The remuneration of the services is entrusted to the Regional Supplementary Agreements in line with the CCA, and the regions will have to report annually on the use of resources (50 million per year) and volumes of activity.

Budget Law, Art. 1, paras. 351-355

Personnel

The expenditure limit for the specificity indemnity of doctors and veterinarians increases up to 412 million per year, that of the health management up to 13.5 million for 2026, for nurses up to 480 million per year, and for OSS up to 208 million per year. In addition, the deadline by which NHS bodies and companies can stabilise staff, including technical-administrative staff hired during the Covid period, is extended to 31 December 2026.

Budget Law, Art. 1 paragraphs 357-360 and 365

Waiting lists

In 2026, for the purpose of reducing waiting lists, regions and the public administration may increase the additional services provided by personnel for a total of 143.5 million euro from the ESF of the 2025 budget. In addition, for the same purpose and in order to cope with the shortage of personnel as from 2026, a waiver of the cap on hiring of up to 450 million euro is allowed within the regional access quota to the NSF. The total personnel expenditure authorised is equal to 3% of the increase in the Regional Health Fund compared to the previous financial year, provided that the Essential Levels of Care are guaranteed. In addition, the resources disbursed in 2020-2021 to cope with the Covid still present in the budgets of the regional health services can be used by 2026 to implement the Waiting List Recovery Plans.

Budget Law, Art. 1 c. 361-364 and c. 937

First Aid

On an experimental basis from 1 January 2026 to 31 January 2029, the regions will be able to increase the remuneration in the form of bonuses and allowances for emergency room staff by up to 1%, in compliance with the law on waiting lists (207/2024)

Budget Law, Art. 1 c. 366

First Aid

Pending an organic regulation on compulsory training in first aid techniques, a fund of 100,000 euros has been set up in the MIM budget for 2026 and 2027 to finance experimental courses for secondary school students and teachers of motor sciences in secondary schools

Budget Law, Art.1 c. 368

Psychologist bonus

From 2026, the management and payment of the 'psychologist bonus' will pass to the Inps, with funding of 200,000 euro a year: it will be used to adapt the IT platform, simplify the procedures for accessing the bonus, and strengthen user support activities

Budget Law, Art. 1 c. 373-375

Celiachia

From 2026 coeliac persons will be able to use an electronic voucher managed by the Sistema Tessera Sanitaria and valid throughout the country that can be used at pharmacies, parapharmacies, specialised shops and supermarkets to purchase gluten-free products. By March 2026, a Ministry of Health decree will define the criteria for generating and using the voucher and for tracking the remaining budget. 2 mln for 2026 and 1 mln from 2027 will be allocated to this measure from the resources earmarked for priority health objectives.

Budget Law, Art. 1 c. 381-385

 

Pharmaceuticals

The Italian Medicines Agency (Aifa) is required to update the handbook of medicines reimbursed by the SSN on an annual basis: review by November and effectiveness from the following January. The pharmaceutical expenditure ceilings are also revised (+0.35%): direct (hospital) expenditure rises to 8.8% (+0.3%) and contracted expenditure to 6.85% (+0.05%). The burden is 490 million per year, covered for 350 million by the increase in the National Health Fund and 140 million by the reduction in the Innovative Medicines Fund, which drops from 1.3 billion to 1.16 billion. The payback mechanism has also been revised: the application of the 1.83% relative to the quotas owed by pharmaceutical companies to the Regions is excluded for a value of €166 million in 2026. From 2026, the option for pharmaceutical companies to avail themselves of the suspension of the 5% 'discount' of the price to the public of medicines used or dispensed by the SSN will be discontinued. Green light to purchasing procedures with Framework Agreement also for non-biologic generic-equivalent drugs.

Budget Law, Art. 1 c. 376-380, 386-389 and 396

Medical devices

The national ceiling for expenditure on medical devices increases from 4.4% to 4.6% (+0.2%) for a total burden of 280 million from the increase in the National Healthcare Fund. A crackdown on the assessment and collection by the Ministry of Health of 0.75% of the turnover for sales to the SSN by medical device suppliers, but companies with a turnover of less than €50,000 are excluded.

Budget Law, Art. 1 c. 399 and 413-417

Purchases from private individuals-accredited

From 2026 onwards, the ceiling on the purchase of healthcare services from accredited private facilities increases further (+1%), at a cost of EUR 123 million per year from the increase in the level of financing of the National Healthcare Fund.

Budget Law, Art. 1 c. 400-401

Hospitals of excellence

In 2026, with 20 million euro to be allocated through a Health-Mef decree and subject to a State-Regions agreement, the experimentation of a clinical-organisational innovation project in the 'top' hospitals of the SSN will start: Institutes of hospitalisation and care of a scientific nature (IRCCS) and hospitals of national importance and high specialisation.

Budget Law, Art. 1 c. 402-404

Italy-EU health data exchange

In order to set up the digital infrastructures to enable the cross-border exchange of electronic medical prescriptions, reports and documents through the Sistema Tessera Sanitaria managed by the MEF, expenditure of approximately EUR 985,222 is authorised for 2026 and EUR 793,000 from 2027.

Budget Law, Art. 1 c. 405-406

Telemedicine

In 2026, the Agency for Regional Health Services (Agenas) is to receive EUR 20 million to be used for the expansion of telemedicine, including the provision of medical devices for patient monitoring to healthcare professionals. A decree of the Ministry of Health will identify the devices and healthcare professionals concerned by June 2026, as well as the allocation modalities.

Budget Law, Art. 1 c. 410-412

Performance and Audit

The system of performance indicators of the national health services envisaged by the 2025 manoeuvre (yet to be identified by decree) is to be supplemented by a permanent monitoring of the balance between the levels and variations of NHS funding and the evolution of the levels of services provided. In addition, the Standing Committee for the Verification of the Essential Levels of Care (Lea) will launch an audit in those Regions that do not reach the minimum guarantee threshold in one or more of the macro areas (prevention, hospital, district) Lea or for individual indicators of the New Guarantee System. The objective is to bring the non-compliant regions to 'sufficiency' in the following two years.

Budget Law, Art. 1 c. 425-426

Health professions 'in derogation'

Prolonged until 31 December 2029 the temporary derogation from the recognition of health professional qualifications obtained abroad, a measure introduced during the pandemic.

Budget Law, Art. 1 para. 939

Simplifications Act

Sickness certificates with televisita

The family doctor will also be able to issue the illness certificate following a telecertification, which is thus equated with an in-person visit. It will be a State-Regions Agreement on the proposal of the Ministry of Health that will define the cases and modalities for the use of telecertification.

Simplifications, Art. 58

Chronics, prescriptions for 12 months

Family doctors will be able to prescribe drugs for chronic illnesses for up to 12 months, thus reducing the need to repeat prescriptions. A Ministry of Health-Mef decree will define by 18 March 2026 (90 days from the entry into force of law 182/2025) the modalities for implementing the rule, which must not entail additional costs for public finance. Prescribed drugs can also be obtained with hospital discharge documentation or emergency room reports without waiting for a second prescription from the family doctor.

Simplifications, Art. 62

Milleproroghe

Non-self-sufficiency

Postponed to September 2026 the choice of the priority criteria for access to the PUAs (Single Points of Access), the composition and the methods of financing the unified multidimensional assessment units for the ascertainment of non-self-sufficiency and for the definition of the Individualised Assistance Plan (Pai). Consequently, the start-up of the experimentation of the unified multidimensional assessment, which is a fundamental element of the non-self-sufficiency reform, is extended by one year: it will start in January 2027 and be fully implemented in January 2028.

Milleproroghe, Art. 4 para. 1

Penal Shield remains

The 'criminal shield' is extended to 31 December 2026: the criminal liability of health professionals in situations of staff shortages is limited to cases of gross negligence for the offences of manslaughter and culpable personal injury.

Milleproroghe, Art. 4 paragraph 3

Free profession confirmed

Extended by one year to 31 December 2026, the suspension of the exclusivity restriction for SSN operators, who will therefore also be able to engage in freelance work subject to authorisation by the local health authority and compliance with specific requirements.

Milleproroghe, Art. 4 para. 8

Specialists in the field

The recruitment of young doctors in various capacities is extended by one year to 31 December 2026: in particular, in order to strengthen the regional health services and to recover waiting lists, trainees will be able to receive six-month self-employment assignments. It is also confirmed that fixed-term recruitment can start as early as the penultimate year of specialisation. Qualified medical graduates will be able to continue in blood and blood component collection.

Milleproroghe, Art. 4 paragraphs 3 and 9

First Aid

Extended to 31 December 2026 the simplified requirements for participation in competitions for medical management in Emergency-Urgency Medicine, also open to those who between January 2013 and January 2024 have accrued at least 3 years of service, even if not continuous, or have a number of hours of activity equal to at least 3 years of service of SSN physicians. In addition, the possibility of requesting part-time work for Ps personnel who can take early retirement is extended to the same date

Milleproroghe, Art. 4 paragraphs 6-7

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti